Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Lysosomal enzyme-cleavable antitumor drug conjugates

Lysosomal enzyme-cleavable antitumor drug conjugates

US Patent 6214345 · Granted Apr 10, 2001

Estimated economic value: $174,675,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating kidney failure, and/or improving or stablizing renal functio2024
Treatment of fibrosis, cardiovascular disease and heart failure with modified re2024
Prodrugs of CGRP antagonists2024
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmace2022
Method of treating cardiovascular disease and heart failure with modified relaxi2021
Pyrimidine carboxamides as GSK-3 inhibitors2021
GSK-3 inhibitors2020
GSK-3 inhibitors2020
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses the2019
Substituted pyridine derivatives useful as GSK-3 inhibitors2017
GSK-3 inhibitors2017
CGRP receptor antagonists2014